questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Utilisations thérapeutiques
Agents hématologiques
Coagulants
Hémostatiques
Hémostatiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Troubles de la coagulation
Tests de coagulation
Tests de coagulation
Hémostatiques
Saignement post-opératoire
Chirurgie
Antécédents médicaux
Anticoagulants
Symptômes
5
Hémorragie interne
Douleur abdominale
Troubles de la coagulation
Saignement
Réaction allergique
Hémostatiques
Prévention
5
Prévention des saignements
Interventions chirurgicales
Anticoagulants
Hygiène dentaire
Anticoagulants
Surveillance médicale
Hémophilie
Prévention des blessures
Éducation des patients
Hémostatiques
Traitements
5
Acide tranexamique
Vitamine K
Administration de médicaments
Hémostatiques
Saignement post-opératoire
Hémostatiques
Agents hémostatiques
Chirurgie
Effets secondaires
Hémostatiques
Complications
5
Réaction allergique
Antihistaminiques
Prévention des complications
Suivi médical
Signes d'alerte
Complications
Facteurs de risque
5
Facteurs de risque
Anticoagulants
Âge
Troubles de la coagulation
Médicaments
Anticoagulants
Maladies hépatiques
Coagulation
Comportements à risque
Alcool
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hémostatiques : Questions médicales les plus fréquentes",
"headline": "Hémostatiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hémostatiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-08",
"dateModified": "2025-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hémostatiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Coagulants",
"url": "https://questionsmedicales.fr/mesh/D003029",
"about": {
"@type": "MedicalCondition",
"name": "Coagulants",
"code": {
"@type": "MedicalCode",
"code": "D003029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.270"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agents d'inversion des anticoagulants",
"alternateName": "Anticoagulant Reversal Agents",
"url": "https://questionsmedicales.fr/mesh/D000089964",
"about": {
"@type": "MedicalCondition",
"name": "Agents d'inversion des anticoagulants",
"code": {
"@type": "MedicalCode",
"code": "D000089964",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.270.463.046"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antifibrinolytiques",
"alternateName": "Antifibrinolytic Agents",
"url": "https://questionsmedicales.fr/mesh/D000933",
"about": {
"@type": "MedicalCondition",
"name": "Antifibrinolytiques",
"code": {
"@type": "MedicalCode",
"code": "D000933",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.270.463.091"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hémostatiques",
"alternateName": "Hemostatics",
"code": {
"@type": "MedicalCode",
"code": "D006490",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Patricia Davenport",
"url": "https://questionsmedicales.fr/author/Patricia%20Davenport",
"affiliation": {
"@type": "Organization",
"name": "Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States."
}
},
{
"@type": "Person",
"name": "Martha Sola-Visner",
"url": "https://questionsmedicales.fr/author/Martha%20Sola-Visner",
"affiliation": {
"@type": "Organization",
"name": "Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States."
}
},
{
"@type": "Person",
"name": "Reihaneh Haghniaz",
"url": "https://questionsmedicales.fr/author/Reihaneh%20Haghniaz",
"affiliation": {
"@type": "Organization",
"name": "Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States."
}
},
{
"@type": "Person",
"name": "Ali Khademhosseini",
"url": "https://questionsmedicales.fr/author/Ali%20Khademhosseini",
"affiliation": {
"@type": "Organization",
"name": "Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States."
}
},
{
"@type": "Person",
"name": "A B Zemlyanoy",
"url": "https://questionsmedicales.fr/author/A%20B%20Zemlyanoy",
"affiliation": {
"@type": "Organization",
"name": "Pirogov National Medical and Surgical Center of Ministry of Health of Russia, Moscow, Russia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Implementation and Consensus.",
"datePublished": "2024-08-19",
"url": "https://questionsmedicales.fr/article/39149952",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/IJG.0000000000002439"
}
},
{
"@type": "ScholarlyArticle",
"name": "International Consensus on Standard Outcome Measures for Neurodevelopmental Disorders: A Consensus Statement.",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38869906",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2024.16760"
}
},
{
"@type": "ScholarlyArticle",
"name": "Expert consensus on oncological [",
"datePublished": "2022-06-25",
"url": "https://questionsmedicales.fr/article/35751696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00330-022-08960-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Consensus and inconsistency between different consensus documents on renal denervation worldwide: the way forward.",
"datePublished": "2022-12-20",
"url": "https://questionsmedicales.fr/article/36103983",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/CM9.0000000000002109"
}
},
{
"@type": "ScholarlyArticle",
"name": "Screening of Glaucoma: Consensus and Directions.",
"datePublished": "2024-06-14",
"url": "https://questionsmedicales.fr/article/39149954",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/IJG.0000000000002449"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Utilisations thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D045506"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents hématologiques",
"item": "https://questionsmedicales.fr/mesh/D006401"
},
{
"@type": "ListItem",
"position": 6,
"name": "Coagulants",
"item": "https://questionsmedicales.fr/mesh/D003029"
},
{
"@type": "ListItem",
"position": 7,
"name": "Hémostatiques",
"item": "https://questionsmedicales.fr/mesh/D006490"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hémostatiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hémostatiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hémostatiques",
"description": "Comment diagnostiquer un trouble de la coagulation ?\nQuels signes indiquent un besoin d'hémostatiques ?\nQuels tests pour évaluer l'efficacité des hémostatiques ?\nComment évaluer un saignement post-opératoire ?\nQuels antécédents médicaux sont pertinents ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Consensus#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hémostatiques",
"description": "Quels sont les symptômes d'un saignement excessif ?\nComment reconnaître une hémorragie interne ?\nQuels signes d'alerte pour les troubles de la coagulation ?\nQuels symptômes d'une réaction aux hémostatiques ?\nComment identifier une thrombose ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Consensus#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hémostatiques",
"description": "Comment prévenir les saignements chez les patients à risque ?\nQuels conseils pour éviter les saignements ?\nComment surveiller les patients sous anticoagulants ?\nQuelles mesures pour les patients hémophiles ?\nComment éduquer les patients sur les hémostatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Consensus#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hémostatiques",
"description": "Quels sont les principaux hémostatiques utilisés ?\nComment administrer des hémostatiques ?\nQuels traitements pour les saignements post-opératoires ?\nQuand utiliser des agents hémostatiques locaux ?\nQuels sont les effets secondaires des hémostatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Consensus#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hémostatiques",
"description": "Quelles complications peuvent survenir avec les hémostatiques ?\nComment gérer une réaction allergique aux hémostatiques ?\nQuels risques de thrombose avec des hémostatiques ?\nComment prévenir les complications liées aux hémostatiques ?\nQuels signes d'alerte pour des complications ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Consensus#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hémostatiques",
"description": "Quels facteurs augmentent le risque de saignement ?\nComment l'âge influence-t-il le risque de saignement ?\nQuels médicaments augmentent le risque de saignement ?\nComment les maladies hépatiques affectent-elles la coagulation ?\nQuels comportements augmentent le risque de saignement ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Consensus#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble de la coagulation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins comme le temps de prothrombine et le temps de saignement sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un besoin d'hémostatiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements excessifs, des ecchymoses fréquentes ou des saignements prolongés peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'efficacité des hémostatiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des tests comme le temps de thrombine et le temps de céphaline activé."
}
},
{
"@type": "Question",
"name": "Comment évaluer un saignement post-opératoire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "On examine la quantité de sang perdu et la durée du saignement après la chirurgie."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont pertinents ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de troubles de la coagulation ou d'utilisation d'anticoagulants sont importants."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un saignement excessif ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des ecchymoses, des saignements de nez fréquents et des gencives qui saignent."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hémorragie interne ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales, des vertiges ou une pâleur peuvent indiquer une hémorragie interne."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour les troubles de la coagulation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements prolongés après une coupure ou des saignements inhabituels sont des signes d'alerte."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une réaction aux hémostatiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou des difficultés respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment identifier une thrombose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement, une douleur ou une rougeur dans une jambe peuvent indiquer une thrombose."
}
},
{
"@type": "Question",
"name": "Comment prévenir les saignements chez les patients à risque ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "On peut prescrire des hémostatiques préventifs avant des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Quels conseils pour éviter les saignements ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les anticoagulants non prescrits et maintenir une bonne hygiène dentaire."
}
},
{
"@type": "Question",
"name": "Comment surveiller les patients sous anticoagulants ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des contrôles réguliers de la coagulation sanguine sont nécessaires pour ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour les patients hémophiles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients hémophiles doivent éviter les sports de contact et suivre un traitement préventif."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les hémostatiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur l'utilisation correcte, les effets secondaires et l'importance du suivi médical."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux hémostatiques utilisés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les hémostatiques courants incluent l'acide tranexamique et la vitamine K."
}
},
{
"@type": "Question",
"name": "Comment administrer des hémostatiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être administrés par voie orale, intraveineuse ou topique selon le type."
}
},
{
"@type": "Question",
"name": "Quels traitements pour les saignements post-opératoires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "On peut utiliser des compresses, des sutures ou des hémostatiques pour contrôler le saignement."
}
},
{
"@type": "Question",
"name": "Quand utiliser des agents hémostatiques locaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés lors de chirurgies pour contrôler les saignements au site opératoire."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des hémostatiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des réactions allergiques, des nausées ou des thromboses."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les hémostatiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des thromboses, des réactions allergiques ou des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique aux hémostatiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut arrêter le traitement et administrer des antihistaminiques ou des corticostéroïdes si nécessaire."
}
},
{
"@type": "Question",
"name": "Quels risques de thrombose avec des hémostatiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation excessive d'hémostatiques peut augmenter le risque de thrombose veineuse profonde."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux hémostatiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un ajustement des doses peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des essoufflements ou des gonflements doivent alerter immédiatement."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de saignement ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, l'utilisation d'anticoagulants et certaines maladies augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque de saignement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées ont un risque accru de troubles de la coagulation et de saignements."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque de saignement ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants, les anti-inflammatoires non stéroïdiens et certains antibiotiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Comment les maladies hépatiques affectent-elles la coagulation ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies hépatiques peuvent altérer la production de facteurs de coagulation, augmentant le risque de saignement."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de saignement ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "La consommation excessive d'alcool et le tabagisme peuvent augmenter le risque de saignement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States.
Publications dans "Hémostatiques" :
2 publications dans cette catégorie
Affiliations :
Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States.
Publications dans "Hémostatiques" :
2 publications dans cette catégorie
Affiliations :
Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States.
Publications dans "Hémostatiques" :
2 publications dans cette catégorie
Affiliations :
Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Pirogov National Medical and Surgical Center of Ministry of Health of Russia, Moscow, Russia.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan. nnhk110184@kpe.biglobe.ne.jp.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
96702State Key Laboratory of NBC Protection for Civilian, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
96702State Key Laboratory of NBC Protection for Civilian, Beijing, PR China.
Publications dans "Hémostatiques" :
The use of evidence-based standardized outcome measures is increasingly recognized as key to guiding clinical decision-making in mental health. Implementation of these measures into clinical practice ...
To develop a core set of outcome measures for specific neurodevelopmental disorders (NDDs), such as attention-deficit/hyperactivity disorder (ADHD), communication disorders, specific learning disorder...
An international working group composed of clinical and research experts and service users (n = 27) was convened to develop a standard core set of accessible, valid, and reliable outcome measures for ...
The final set recommends measuring 12 outcomes across 3 key domains: (1) core symptoms related to the diagnosis; (2) impact, functioning, and quality of life; and (3) common coexisting problems. The f...
The NDD set covers outcomes of most concern to patients and caregivers. Use of the NDD set has the potential to improve clinical practice and research....
[...
The consensus was summarized based on the published guidelines and peer-reviewed articles of TB PET/CT in the literature, along with the opinions of the experts from major research institutions with a...
This consensus describes the protocols for routine and dynamic [...
This expert consensus focuses on the reduction of acquisition time and FDG injected activity with a TB PET/CT scanner, which may improve the patient throughput or reduce the radiation exposure in dail...
• [...
Given the unsatisfactory hypertension control rates and high rates of non-adherence to antihypertensive medications worldwide, device therapy which can safely provide durable blood pressure-lowering e...
Glaucoma is a leading public health concern globally. This summary discusses barriers to glaucoma screening and novel strategies for a cost-effective glaucoma screening....
We discuss barriers to glaucoma screening and recent advancements in glaucoma detection and care, including targeted screening approach as well as telemedicine, genetic testing, and artificial intelli...
Screening of glaucoma is challenging and changing. Recent advancements in digital technology and genetics have led to the development of tools that are promising for novel screening methodologies. Cli...
Hernia repairs are a commonly performed surgical procedure and the Shouldice Repair of inguinal hernias has been well described before in terms of its outcomes. However, the purpose of this paper was ...
Utilizing a Delphi Methodology, surgeons at Shouldice Hospital who are considered content experts, provided their answers on what is essential to the Shouldice Method. The median, interquartile range,...
The final consensus for the Shouldice Method included 39 items with 7 overarching steps: preoperative preparation of the patient, anesthetic component, incision and nerve identification, treatment of ...
The results of this consensus provide a step-by-step approach to the Shouldice Method, as well as information that is timely and can be utilized by surgeons incorporating non-mesh hernia repairs into ...
Multiview subspace learning has attracted much attention due to the efficacy of exploring the information on multiview features. Most existing methods perform data reconstruction on the original featu...
Cryo-EM particle identification from micrographs ("picking") is challenging due to the low signal-to-noise ratio and lack of ground truth for particle locations. State-of-the-art computational algorit...
Using an expert consensus-based approach, a netball video analysis consensus (NVAC) group of researchers and practitioners was formed to develop a video analysis framework of descriptors and definitio...
The rapid adoption of robotic surgical systems across Europe has led to a critical gap in training and credentialing for gastrointestinal (GI) surgeons. Currently, there is no existing standardised cu...
In Stage 1, a Steering Committee, consisting of international experts, trainees and educationalists, has been established to lead and coordinate the consensus development process. In Stage 2, a system...
The study protocol has been registered on the Open Science Framework (https://osf.io/br87d/)....